Introduced 30 years ago, reperfusion therapies have become standard of care in the acute management of ST elevation MI. The criteria for assessing success of these strategies have not kept apace with the refinement of primary PCI systems of care. It is about time these legacy measures shaped by early reperfusion trial criteria are updated to reflect the predominant focus of contemporary clinical practice.
Audience Take Away:
• Revisiting historical criteria for gauging reperfusion success
• Shifting focus to what really matters in the acute treatment of STEMI
• Redefining key performance indicators • Shaping future trial design and endpoints